Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
NCT00640601
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
331
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Quetiapine Fumarate Extended- Release
Sponsor
AstraZeneca